Free Trial

Virax Biolabs Group (VRAX) SEC Filings & 10K Form

Virax Biolabs Group logo
$1.01 +0.02 (+1.50%)
As of 11:00 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Virax Biolabs Group SEC Filings

DateFilerForm TypeView
03/18/2025
7:10 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2025
7:13 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2025
6:44 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
6:25 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
7:50 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
7:30 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2024
6:36 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
7:09 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
7:50 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
8:13 AM
Virax Biolabs Group (Filer)
Form 424B5
09/30/2024
8:14 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
7:54 AM
Virax Biolabs Group (Filer)
Form 424B5
08/23/2024
7:55 AM
Virax Biolabs Group (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2024
3:24 PM
Virax Biolabs Group (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
08/01/2024
6:48 AM
Virax Biolabs Group (Filer)
Form NT 20-F
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRAX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners